Counterfeit Drug Detection Device companies

  • Report ID: 6470
  • Published Date: Jan 10, 2025
  • Report Format: PDF, PPT

Companies Dominating the Counterfeit Drug Detection Device Landscape

    The counterfeit drug detection device market is highly competitive, with the presence of some major key players trying to vie for market share. Key players including B&W Tek, Metrohm AG, Thermo Fisher Scientific Inc., and Rigaku Corporation, are actively developing research and development to come up with innovations and technologically advanced solutions to detect counterfeit drugs.

    These companies are also focusing on strategic partnerships, mergers, and acquisitions to expand their presence in the market and expand their portfolios of products. In December 2021, Thermo Fisher Scientific Inc. acquired a leading provider of portable chemical analysis solutions step in strengthening its position in the counterfeit drug detection device market. It will significantly expand the customer base and the portfolio of Thermo Fisher's product line, boosting the competition in the market.

    Here are some leading companies in the counterfeit drug detection device market

    • B&W Tek
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Metrohm AG
    • Thermo Fisher Scientific Inc.
    • Rigaku Holding Corporation
    • Konica Minolta Business Solutions Europe GmbH
    • Nynomic AG
    • Bruker
    • Eluceda Ltd
    • NanoMatrix Technologies Limited
    • GAO RFID Inc.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of counterfeit drug detection device is evaluated at USD 1.58 billion.

The counterfeit drug detection device market size was valued at USD 1.51 billion in 2024 and is set to exceed USD 2.99 billion by 2037, expanding at over 5.4% CAGR during the forecast period i.e., between 2025-2037.

North America industry is anticipated to hold largest revenue share of 34.2% by 2037, due to rising awareness of the dangers of counterfeit drugs and improvement in healthcare infrastructure in the region

The major players in the market include B&W Tek, Metrohm AG, Thermo Fisher Scientific Inc., Rigaku Holding Corporation, Konica Minolta Business Solutions Europe GmbH, Nynomic AG, Bruker, Eluceda Ltd, NanoMatrix Technologies Limited, and GAO RFID Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos